Boothby's tardigrade-glass finding showed dried enzymes can survive without a cold chain

Vaccines and many medicines are delicate proteins that fall apart when they dry, which is why they are shipped and stored cold from factory to clinic. That refrigeration is the single biggest line in the bill: around 80 percent of the costs of vaccination programs in developing countries comes from keeping vaccines cold, Boothby and colleagues reported. The obvious fix is more and better cold chain -- fridges, boxes, power -- infrastructure that must run forever.

Tardigrades, the microscopic water bears, survive losing almost all the water in their cells. In September 2015, University of Chicago researchers announced the animals coat themselves in glassy molecules as they dry. Thomas Boothby at the University of North Carolina then found the machinery: tardigrade-specific genes for intrinsically disordered proteins (IDPs), shapeless when hydrated, that multiply during drying and rearrange into solid biological glass encasing essential proteins and molecules. Add water and the glass melts back into floppy proteins.

Boothby showed the mechanism is dedicated to drying, not general hardiness: tardigrades engineered to make less IDP lost desiccation tolerance but kept cold resistance. The trick transfers: in human HeLa cells the IDPs moved to specific organelles as cells dried and formed glass in vitro; yeast and bacteria engineered to make the proteins survived extreme drying better than normal. Lactate dehydrogenase bounced back to full activity when mixed with glass proteins before drying; adding them afterwards did nothing, proving the glass must form around molecules as the water leaves.

The same envelope could stabilise dried enzymes and eventually vaccines, letting them travel and sit on a shelf without the cold chain, and the proteins also point toward drought-resistant crops. The mechanism is not yet a product -- as of the December 2015 reports the evidence was cells and enzymes, not a vaccine shipped warm -- but it reframes the problem: instead of protecting the cargo with infrastructure, make the cargo protect itself.

Don't cool the cargo; borrow the tardigrade trick and make dried biomolecules self-protecting

It attacks the dominant cost: if refrigeration is about 80 percent of developing-country vaccination-program cost, a biologic that tolerates drying removes the biggest expense

The glass is reversible and targeted: it melts on rehydration and it must form around molecules while water is leaving, so protection is built into the drying process rather than added later

The mechanism was proven portable: knockdowns showed the genes are specific to desiccation, and expressing them in yeast, bacteria and HeLa cells reproduced the effect outside the tardigrade

The work was presented at the American Society for Cell Biology meeting and reported by independent science press in December 2015, giving the finding a verifiable public record

When keeping something alive is expensive, change the product tolerance rather than the environment: find an organism that survives the hostile condition and transplant its mechanism.

As reported in December 2015, the work had just been presented at the annual meeting of the American Society for Cell Biology; the demonstrated results were in yeast, bacteria, human cells and an enzyme assay, with dry-stable vaccines and drought-resistant crops named as the intended applications rather than finished outcomes. Both ScienceAlert and Science News ran the story that month, and the ScienceAlert write-up drew 194 points and 37 comments on Hacker News on Christmas Day 2015. Whether the glass-protein approach would reach a real vaccine or crop remained open at the time of reporting.